Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor suppressor gene mutations correlate with prognosis and immunotherapy benefit in hepatocellular carcinoma
Zaoqu Liu, Long Liu, Chunguang Guo, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108340-108340
Closed Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Histone Acetylation Regulator-Mediated Acetylation Patterns Define Tumor Malignant Pathways and Tumor Microenvironment in Hepatocellular Carcinoma
Yuyan Xu, Wei Liao, Qiong Luo, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 37
ASF1B Serves as a Potential Therapeutic Target by Influencing Cell Cycle and Proliferation in Hepatocellular Carcinoma
Xiaoxi Ouyang, Longxian Lv, Yalei Zhao, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 28
A novel ubiquitin-related genes-based signature demonstrated values in prognostic prediction, immune landscape sculpture and therapeutic options in laryngeal cancer
Lu Liu, Bing Wang, Xiaoya Ma, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Integrated Exploration of Epigenetic Dysregulation Reveals a Stemness/EMT Subtype and MMP12 Linked to the Progression and Prognosis in Hepatocellular Carcinoma
Anning Zuo, Jinyu Li, Siyuan Weng, et al.
Journal of Proteome Research (2024) Vol. 23, Iss. 5, pp. 1821-1833
Closed Access | Times Cited: 3
Sortilin 1 Promotes Hepatocellular Carcinoma Cell Proliferation and Migration by Regulating Immune Cell Infiltration
Yan Gao, Yan Li, Ziyan Song, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 14
Pan-Cancer Analysis Identified CD93 as a Valuable Biomarker for Predicting Patient Prognosis and Immunotherapy Response
Wen Tong, Guangyu Wang, Liuyang Zhu, et al.
Frontiers in Molecular Biosciences (2022) Vol. 8
Open Access | Times Cited: 13
Identification of the Tumor Immune Microenvironment and Therapeutic Biomarkers by a Novel Molecular Subtype Based on Aging-Related Genes in Hepatocellular Carcinoma
Dong Cai, Zhibo Zhao, Jie‐Jun Hu, et al.
Frontiers in Surgery (2022) Vol. 9
Open Access | Times Cited: 12
Glycolysis-related gene dihydrolipoamide acetyltransferase promotes poor prognosis in hepatocellular carcinoma through the Wnt/β-catenin and PI3K/Akt signaling pathways
Yuan Zhou, Haijuan Gu, Bingfeng Shao, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 22, pp. 1240-1240
Open Access | Times Cited: 12
Comprehensive analysis of single cell and bulk data develops a promising prognostic signature for improving immunotherapy responses in ovarian cancer
Huanfei Ding, Bowen Hu, Ruixia Guo
PLoS ONE (2024) Vol. 19, Iss. 2, pp. e0298125-e0298125
Open Access | Times Cited: 2
Pyroptosis-Related Signature as Potential Biomarkers for Predicting Prognosis and Therapy Response in Colorectal Cancer Patients
Zhiyong Li, Yang Liu, Baiqiang Lin, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 11
Prognostic significance of TNFRSF4 expression and development of a pathomics model to predict expression in hepatocellular carcinoma
Zhaoyong Yan, Xiang Li, Zeyu Li, et al.
Heliyon (2024) Vol. 10, Iss. 11, pp. e31882-e31882
Open Access | Times Cited: 2
Construction of a Novel LncRNA Signature Related to Genomic Instability to Predict the Prognosis and Immune Activity of Patients With Hepatocellular Carcinoma
Jinfeng Zhu, Qian Huang, Sicheng Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 9
Molecular Characterization Clinical and Immunotherapeutic Characteristics of m5C Regulator NOP2 Across 33 Cancer Types
Taisheng Liu, Jian Zhang, Chunxuan Lin, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 8
Modulation of Lymphocyte Functions in the Microenvironment by Tumor Oncogenic Pathways
Barbara Seliger, Chiara Massa
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Necroptosis throws novel insights on patient classification and treatment strategies for hepatocellular carcinoma
Bowen Hu, Jie Gao, Jihua Shi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
A prognostic signature of pyroptosis-related lncRNAs verified in gastric cancer samples to predict the immunotherapy and chemotherapy drug sensitivity
Yanan Wang, Xiaowei Chen, Fei Jiang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 7
m6A Methylation Patterns and Tumor Microenvironment Infiltration Characterization in Clear-Cell Renal Cell Carcinoma
Tianming Ma, Jiawen Wang, Xiaodong Liu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 6
The Prognostic Significance and Potential Mechanism of Ferroptosis-Related Genes in Hepatocellular Carcinoma
Wenli Li, Jun Liu, Dangui Zhang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 6
Identification of N7-methylguanosine-related lncRNAs for the risk stratification of hepatocellular carcinoma
Yilin Li, Ke Zhao, Ruike Wu, et al.
Journal of Gastrointestinal Oncology (2023) Vol. 14, Iss. 3, pp. 1392-1411
Open Access | Times Cited: 3
Development and Validation of Ischemic Events Related Signature After Carotid Endarterectomy
Chunguang Guo, Zaoqu Liu, Can Cao, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 5
Positive Correlation Between LTA Expression and Overall Immune Activity Suggests an Increased Probability of Survival in Uterine Corpus Endometrial Carcinoma
Mingjie Shi, Fei Luo, Taotao Shao, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 4
Identification of immune-related genes and patient selection for hepatocellular carcinoma immunotherapy
Zhendong Chen, Jia‐Yuan Luo, Yuping Ye, et al.
Translational Cancer Research (2023) Vol. 12, Iss. 5, pp. 1210-1231
Open Access | Times Cited: 2
Advancements of the CRISPR/Cas9 System in the Treatment of Liver Cancer
Zhuoyu Li, Han Zi-ming
Current Protein and Peptide Science (2023) Vol. 25, Iss. 2, pp. 154-162
Closed Access | Times Cited: 2
Diagnosis and prognosis prediction model for digestive system tumors based on immunologic gene sets
Lin Zhou, Chunyu Wang
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
The Pretreatment Neutrophil-to-Lymphocyte Ratio (NLR) as a Near-term Prognostic Indicator in Patients with Locally Advanced Hepatocellular Carcinoma Treated with Hepatic Artery Infusion Chemotherapy: A Propensity Score Matching Cohort Study
Weifu Liu, Kongzhi Zhang, Shiguang Chen, et al.
Research Square (Research Square) (2024)
Open Access
Page 1 - Next Page

Scroll to top